Cyteir Therapeutics, Inc.
CYT · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,532 | -$8,404 | -$12,486 | -$8,793 |
| Dep. & Amort. | $110 | $108 | $150 | $170 |
| Deferred Tax | -$1,640 | -$319 | $0 | $0 |
| Stock-Based Comp. | $599 | $776 | $1,042 | $869 |
| Change in WC | -$1,733 | $3,371 | $362 | $681 |
| Other Non-Cash | $1,640 | $319 | $765 | $156 |
| Operating Cash Flow | -$4,556 | -$4,149 | -$10,167 | -$6,917 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$302 |
| Net Acquisitions | $0 | $153 | $150 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $153 | $150 | -$302 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $164 | $428 | $61 | $64 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $164 | $428 | $103 | $147 |
| Financing Cash Flow | $164 | $428 | $103 | $147 |
| Forex Effect | $0 | $0 | $0 | $302 |
| Net Chg. in Cash | -$4,392 | -$3,568 | -$9,914 | -$6,770 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $133,895 | $137,463 | $147,377 | $154,147 |
| End Cash | $129,503 | $133,895 | $137,463 | $147,377 |
| Free Cash Flow | -$4,556 | -$4,149 | -$10,167 | -$7,219 |